Exclusive patents may already be keeping some patients in the dark, the WSJ article says. It describes a new method of genetic testing called chromosomal microarrays that can pick up chromosomal abnormalities in the genome. What’s a doctor to do if that kind of analysis encompasses a gene that’s already patented — tell the patient or stick to the letter of the law?
Our genes have to be open source. It’s that simple. See why here.